Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Elastomeric infusion pumps are also called as balloon pumps, which are generally used to administer liquid drugs such as local anesthetics, analgesic, cytostatic, and antibiotics. Elastomeric pumps do not require any electricity, when these pumps are placed on the patient  the flow rate of the pumps  is typically increased or decreased, which means the elastomeric pumps are manually operated pumps and also the not affected by gravity . The elastomeric pumps are maintenance free due to no use of electricity and are single use disposable.

The U.S. elastomeric infusion pumps market is estimated to be valued at US$ 258.3 million in 2021 and is expected to exhibit a CAGR of 5.7 % during the forecast period (2022-2028).

Figure 1. U.S. Elastomeric Infusion Pumps Market Value (US$ Mn), 2017-2028

U.S. Elastomeric Infusion Pump  | Coherent Market Insights

The increasing incidence of chronic diseases is expected to drive the market growth over the forecast period.  According to the Centers for Disease Control and Prevention Report published on September 2020, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the U.S., and one person dies every 36 seconds in the U.S. from cardiovascular disease.

Moreover, the increasing R&D for novel applications of elastomeric infusion pumps is expected to drive the market growth over the forecast period. For instance, in September 2018, researchers from University Hospital of Lausanne, Switzerland, assessed the use of two sub-muscular catheters connected to two elastomeric pumps in post-operative continuous wound.  

request-sample

U.S. Elastomeric Infusion Pumps Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 258.3 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2020 to 2027
Forecast Period 2022 to 2028 CAGR: 5.7% 2028 Value Projection: US$ 380.7 Mn
Geographies covered:
  • U.S.
Segments covered:
  • By Product Type: Variable Rate Elastomeric Pumps, Continuous Rate Elastomeric Pumps
  • By Indication: Oncology, Post-operative Care, General Medicine, Others
  • By End User: Ambulatory Surgical Centers, Clinics
    • Home Care Settings: Oncology, Post-operative Care, General Medicine, Others
    • Hospitals, Others
Companies covered:

B. Braun Melsungen AG, Baxter International Inc., Werfen, Ambu A/S, Avanos Medical Inc., NIPRO, and Progressive Medical, Inc.

Growth Drivers:
  • Increasing incidence of chronic diseases such as cancer 
  • Advantages of elastomeric pumps 
Restraints & Challenges:
  • Stringent regulations regarding the use of plastics in elastomeric infusion pumps
  • High cost of infusion pumps

U.S. Elastomeric Infusion Pumps Market – Impact of Coronavirus (COVID-19)

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it as a public health emergency. According to the World Health Organization’s report, manifestation of coronavirus (COVID-19) has resulted in over 162 million infected individuals worldwide as of May 17, 2021.

The coronavirus (COVID-19) pandemic and resulting lockdown in various countries across the globe has impacted the financial status of major companies in urea cycle disorders product market. The private healthcare sector is one of the sectors, which has been majorly impacted by the COVID-19 pandemic. The pandemic has negatively impacted the U.S. elastomeric infusion pumps market in various aspects such as research and development, production, and supply of medicines. The pandemic has also affected the growth of pharmaceutical businesses of various companies across the globe due to lockdowns implemented by governments of several countries.

Figure 2. U.S. Elastomeric Infusion Pumps Market Share (%), By Product Type, 2028

U.S. Elastomeric Infusion Pump  | Coherent Market Insights

Moreover, stringent regulations regarding the use of plastics in elastomeric infusion pumps is expected to hamper the market growth. For instance, the European Commission and the U.S. FDA published safety assessments of medical devices containing Di (2-ethylhexyl) phthalate (DEHP) and plasticized polyvinylchloride (PVC) in certain parts of elastomeric infusion pumps.

Therefore, manufacturers need to focus on proper safety labelling of products to avoid severe side effects, especially in neonatal patient population.

Furthermore, the cost of elastomeric infusion pumps keep fluctuating depending on the type of the pump.

For instance, the cost of pumps administering antibiotics is significantly low, whereas the cost of pumps administering pain management drugs is relatively high and ranges between US$ 160 and US$ 450. Such factors is expected to hinder growth of the U.S. elastomeric infusion pumps market over the forecast period.

Key Players

Major players operating in the U.S. elastomeric infusion pumps market include B. Braun Melsungen AG, Baxter International Inc., Werfen, Ambu A/S, Avanos Medical Inc., NIPRO and Progressive Medical, Inc.

The U.S. elastomeric infusion pumps market includes various products such as variable rate elastomeric pumps and continuous rate elastomeric pumps which are used for the treatment of various indication such as oncology, post- operative care, general medicine, and others. The elastomeric infusion pumps are used to deliver the medication through intravenous route through IV line, the medication prescribed is filled in the chamber and the pressure is applied to the balloon for delivery of medication.

Market Dynamics

The increasing usage of antibiotics and other anti-infective drugs for the treatment of infectious diseases is expected to drive the segment growth over the forecast period

For instance, according to the Report of Centers for Disease Control and Prevention, in 2016, 270.2 million antibiotic prescriptions were written in the U.S.  Increasing application of elastomeric infusion pumps in outpatient parenteral antimicrobial therapy is expected to boost the growth of the market

The increasing incidence of chronic blood diseases such as blood cancers which include leukemia, lymphoma, and myeloma or blood disorder such as anemia, bleeding disorders such as blood clots and hemophilia is expected to drive the segment growth over the forecast period.

According to the Centers for Disease Control and Prevention (CDC) in 2019, the Sickle Cell Disease (SCD) affects around 100,000 Americans each year. Moreover, according to Leukemia & Lymphoma Society, it was estimated that around 172,910 people in the U.S. were expected to be diagnosed with the leukemia, lymphoma or myeloma in 2017.

 Key features of the study:

  • This report provides in-depth analysis of the U.S. elastomeric infusion pumps market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2022–2028)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
  • It profiles leading players in the U.S. elastomeric infusion pumps market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future market expansion, and marketing tactics
  • The U.S. elastomeric infusion pumps market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the U.S. elastomeric infusion pumps market

 Detailed Segmentation:

  • U.S. Elastomeric Infusion Pumps Market, By Product Type :
    • Variable Rate Elastomeric Pumps
    • Continuous Rate Elastomeric Pumps
  • U.S. Elastomeric Infusion Pumps Market, By Indication :
    • Oncology
    • Post-operative Care
    • General Medicine
    • Others
  • U.S. Elastomeric Infusion Pumps Market, By End User :
    • Ambulatory Surgical Centers
    • Clinics
    • Home Care Settings
      • Oncology
      • Post-operative Care
      • General Medicine
      • Others
    • Hospitals
    • Others
  • Company Profiles
    • B. Braun Melsungen AG.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Baxter International Inc.
    • Werfen
    • Ambu A/S
    • Avanos Medical Inc.
    • Aeglea BioTherapeutics
    • NIPRO
    • Progressive Medical, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Indication
      • Market Snapshot, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Opportunities
    • Impact Analysis
    • Collaboration & Acquisition
    • Market Trends
    • Regulatory Scenario
    • PEST Analysis
    • Major Brand Analysis
    • Disposable Balloon Infusion Pump VS Electric/Programmable Infusion Control System
    • Pricing Analysis
  4. U.S. Elastomeric Infusion Pumps Market - Impact of COVID-19 Pandemic
    • Impact on Supply and Demand
    • Impact on Overall Healthcare
    • Government Initiatives
  5. U.S. Elastomeric Infusion Pumps Market, By Product Type, 2017-2028 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018–2028
      • Segment Trends
        • Variable Rate Elastomeric Pumps
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
        • Continuous Rate Elastomeric Pumps
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
  6. U.S. Elastomeric Infusion Pumps Market, By Indication , 2017-2028 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018–2028
      • Segment Trends
        • Oncology
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
        • Post-operative Care
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
        • General Medicine
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
  7. U.S. Elastomeric Infusion Pumps Market, By End User, 2017–2028 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018–2028
    • Segment Trends
      • Ambulatory Surgical Centers
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
      • Clinics
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
      • Home Care Settings
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
          • Oncology
          • Post-operative Care
          • General Medicine
          • Others
      • Hospitals
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
      • Others
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2017–2028, (US$ Mn)
  8. Competitive Landscape
    • Company Profiles
      • B. Braun Melsungen AG.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Werfen
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Ambu A/S
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Avanos Medical Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • NIPRO
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Progressive Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 10 market data tables and 19 figures on “U.S. Elastomeric Infusion Pumps Market – U.S. Forecast to 2028”.

FAQgrowicon

Frequently Asked Questions

The U.S. Elastomeric Infusion Pumps market size is estimated to be valued at US$ 258.3 million in 2021 and is expected to exhibit a CAGR of 5.7% between 2021 and 2028.
Increasing incidence of chronic diseases such as cancer and advantages of elastomeric pumps are expected to drive growth of the market.
Continuous rate elastomeric pumps is estimated to hold major market share in the market during the forecast period, owing to the increasing product offerings of automated and technologically advanced continuous rate elastomeric pumps by major players in the market.
Oncology segment is estimated to hold major market share in the market during the forecast period, owing to increasing incidence of cancer in the U.S.
Hospital segment is estimated to hold major market share in the market during the forecast period, owing to increasing hospital spending by cancer patients in U.S. for treatment of cancers.
High cost of infusion pumps are the key factors that are expected to hamper growth of the market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.